These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 28756098)

  • 1. Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach.
    Paci M; Passini E; Severi S; Hyttinen J; Rodriguez B
    Heart Rhythm; 2017 Nov; 14(11):1704-1712. PubMed ID: 28756098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells.
    Ma D; Wei H; Zhao Y; Lu J; Li G; Sahib NB; Tan TH; Wong KY; Shim W; Wong P; Cook SA; Liew R
    Int J Cardiol; 2013 Oct; 168(6):5277-86. PubMed ID: 23998552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic Hit to Lead Refinement in a Dish Using Patient-Derived iPSC Cardiomyocytes.
    Cashman JR; Ryan D; McKeithan WL; Okolotowicz K; Gomez-Galeno J; Johnson M; Sampson KJ; Kass RS; Pezhouman A; Karagueuzian HS; Mercola M
    J Med Chem; 2021 May; 64(9):5384-5403. PubMed ID: 33942619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes.
    Paci M; Casini S; Bellin M; Hyttinen J; Severi S
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD+/- and human SCN5A-1795insD+/- iPSC-derived cardiomyocytes.
    Portero V; Casini S; Hoekstra M; Verkerk AO; Mengarelli I; Belardinelli L; Rajamani S; Wilde AAM; Bezzina CR; Veldkamp MW; Remme CA
    Cardiovasc Res; 2017 Jun; 113(7):829-838. PubMed ID: 28430892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
    Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
    Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity.
    McKeithan WL; Feyen DAM; Bruyneel AAN; Okolotowicz KJ; Ryan DA; Sampson KJ; Potet F; Savchenko A; Gómez-Galeno J; Vu M; Serrano R; George AL; Kass RS; Cashman JR; Mercola M
    Cell Stem Cell; 2020 Nov; 27(5):813-821.e6. PubMed ID: 32931730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
    Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome.
    Sicouri S; Antzelevitch D; Heilmann C; Antzelevitch C
    J Cardiovasc Electrophysiol; 1997 Nov; 8(11):1280-90. PubMed ID: 9395171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study.
    Millard D; Dang Q; Shi H; Zhang X; Strock C; Kraushaar U; Zeng H; Levesque P; Lu HR; Guillon JM; Wu JC; Li Y; Luerman G; Anson B; Guo L; Clements M; Abassi YA; Ross J; Pierson J; Gintant G
    Toxicol Sci; 2018 Aug; 164(2):550-562. PubMed ID: 29718449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repolarization instability and arrhythmia by IKr block in single human-induced pluripotent stem cell-derived cardiomyocytes and 2D monolayers.
    Altrocchi C; de Korte T; Bernardi J; Spätjens RLHMG; Braam SR; Heijman J; Zaza A; Volders PGA
    Europace; 2020 Sep; 22(9):1431-1441. PubMed ID: 32770183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eleclazine exhibits enhanced selectivity for long QT syndrome type 3-associated late Na
    El-Bizri N; Xie C; Liu L; Limberis J; Krause M; Hirakawa R; Nguyen S; Tabuena DR; Belardinelli L; Kahlig KM
    Heart Rhythm; 2018 Feb; 15(2):277-286. PubMed ID: 29017927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.
    Nasilli G; Yiangou L; Palandri C; Cerbai E; Davis RP; Verkerk AO; Casini S; Remme CA
    Europace; 2023 Jun; 25(6):. PubMed ID: 37369559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapies.
    Stutzman MJ; Gao X; Kim M; Ye D; Zhou W; Tester DJ; Giudicessi JR; Shannon K; Ackerman MJ
    Heart Rhythm; 2023 May; 20(5):709-717. PubMed ID: 36731785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction.
    Malan D; Zhang M; Stallmeyer B; Müller J; Fleischmann BK; Schulze-Bahr E; Sasse P; Greber B
    Basic Res Cardiol; 2016 Mar; 111(2):14. PubMed ID: 26803770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SGK1 inhibition attenuates the action potential duration in reengineered heart cell models of drug-induced QT prolongation.
    Kim M; Sager PT; Tester DJ; Pradhananga S; Hamrick SK; Srinivasan D; Das S; Ackerman MJ
    Heart Rhythm; 2023 Apr; 20(4):589-595. PubMed ID: 36610526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block.
    Paci M; Hyttinen J; Rodriguez B; Severi S
    Br J Pharmacol; 2015 Nov; 172(21):5147-60. PubMed ID: 26276951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
    Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes.
    Lee HA; Hyun SA; Byun B; Chae JH; Kim KS
    PLoS One; 2018; 13(4):e0195577. PubMed ID: 29630634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
    Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
    Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.